Cargando…
Recent drug approvals for acute myeloid leukemia
Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults, with an incidence that increases with age, and a generally poor prognosis. The disease is clinically and genetically heterogeneous, and recent advances have improved our understanding of the cytogenetic abnormalities a...
Autores principales: | Lai, Catherine, Doucette, Kimberley, Norsworthy, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749668/ https://www.ncbi.nlm.nih.gov/pubmed/31533852 http://dx.doi.org/10.1186/s13045-019-0774-x |
Ejemplares similares
-
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
por: Stanchina, Michele, et al.
Publicado: (2020) -
Recent advances in targeted therapies in acute myeloid leukemia
por: Bhansali, Rahul S., et al.
Publicado: (2023) -
Optimizing Use of Newly Approved Agents for Acute Myeloid Leukemia
por: Nix, Nancy M., et al.
Publicado: (2019) -
Paradigm Shift in the Management of Acute Myeloid Leukemia—Approved Options in 2023
por: Premnath, Naveen, et al.
Publicado: (2023) -
New drug approvals in acute myeloid leukemia: what’s the best end point?
por: Estey, E, et al.
Publicado: (2015)